Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing olanzapine and mirtazapine to improve unintentional weight loss in patients with anorexia nervosa and significantly low body …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)
  • olanzapine (olanzapine)

Snippet

Sponsor: Englewood Hospital and Medical Center | Conditions: Anorexia Nervosa with Significantly Low Body Weight | Phase 2 | Status: ENROLLING_BY_INVITATION